RNA metabolism in ALS: when normal processes become pathological.
about
ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the diseaseNovel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked SystemsProteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1.The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.Calcium-responsive transactivator (CREST) protein shares a set of structural and functional traits with other proteins associated with amyotrophic lateral sclerosis.Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS.Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.ALS mutant SOD1 interacts with G3BP1 and affects stress granule dynamicsDrosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular DiseasesChallenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.MotomiRs: miRNAs in Motor Neuron Function and Disease.Novel miR-b2122 regulates several ALS-related RNA-binding proteins.Dysregulation of microRNA biogenesis machinery and microRNA/RNA ratio in skeletal muscle of amyotrophic lateral sclerosis mice.Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing
P2860
Q28392297-D06ABF62-44A8-40EA-BE55-B67976805712Q28552814-AA98FD19-F29B-4BBB-A89B-99C47C07B16CQ30354368-2C6A7734-1BDD-4615-82A5-5711F8A03940Q34159126-0EEBE50B-57B3-4DA9-8CF3-B809EC92799DQ35596823-54E39EC1-E9C7-43F1-818B-8586DECA732AQ36270953-DC1A8D25-1BEE-4EFE-B761-A6039AFD8975Q37180715-1283D458-F888-4D8E-B951-4EA2799ACE15Q37256571-4DDAEE05-D6A2-4B4D-AC55-042205B3CD83Q37713198-0EC1767E-14F5-4B52-8689-C8A248DC2F86Q38312121-3D1C11DD-23D5-4AA9-815D-B16677CE5679Q39316843-C1C578D3-3A95-47E8-A59A-30E86A016D28Q42284681-36806B85-5FCE-47FF-8632-A34EF0DDFC1CQ47918174-D5254A78-940B-41C3-9F64-67BC37E5AAE9Q58781301-BA9D771E-49B7-4C1E-A9E5-CF123756DA3B
P2860
RNA metabolism in ALS: when normal processes become pathological.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
RNA metabolism in ALS: when normal processes become pathological.
@en
type
label
RNA metabolism in ALS: when normal processes become pathological.
@en
prefLabel
RNA metabolism in ALS: when normal processes become pathological.
@en
P2093
P2860
P1476
RNA metabolism in ALS: when normal processes become pathological
@en
P2093
Cristian A Droppelmann
Danae Campos-Melo
Kathryn Volkening
Muhammad Ishtiaq
P2860
P304
P356
10.3109/21678421.2014.881377
P577
2014-02-20T00:00:00Z